MetLife Launches Cancer Support Benefit to Help Employees Understand and Navigate Care Options as Cancer Diagnoses Continue to Rise
Through a strategic collaboration with Private Health Management, new offering provides individuals with expert-guided cancer education and financial support
“Our new Cancer Support benefit raises the bar in delivering compassionate, expert-led guidance at a time when individuals are facing one of life’s most difficult moments,” said Chris Swanker, senior vice president, Group Benefits Products at MetLife. “For employers, it’s a meaningful way to support their employees, offering a benefit that can make a difference in how they navigate the complexities of a cancer diagnosis and improve patient outcomes. As cancer costs continue to rise, this benefit also has been proven to reduce overall medical costs for employees and employers alike.”
One in every three Americans will develop cancer in their lifetime,1 and those impacted by cancer are
As part of the collaboration, Private Health Management's team of experienced professionals will work closely with MetLife to ensure that covered policyholders receive individualized counseling and attention, helping them navigate the complexities of cancer treatment and recovery. Employers who have deployed Private Health Management services have seen strong outcomes,3 including:
-
-
-
-
- 2-4 times improvement in survival for late-stage cancers
"MetLife is building a truly comprehensive benefits experience – adding a Cancer Support benefit will be a critical element," said Ken Tarkoff, CEO of Private Health Management. "At Private Health Management, our mission is to empower patients with the knowledge, resources, and support they need to achieve the best possible outcomes. We are excited to team up with MetLife to bring that promise to more patients in their cancer treatment and recovery journeys."
MetLife’s Cancer Support benefit will be available to MetLife Critical Illness insureds with covered cancer conditions, beginning January 1, 2026. To learn more about MetLife’s Critical Illness Insurance and Cancer Support benefit, visit our website or email directly.
About MetLife
MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in
About PHM
Private Health Management (PHM) is a clinically sophisticated complex care management company that provides guidance for individuals facing serious medical conditions like cancer. PHM connects clients with top specialists, cutting-edge diagnostics, and personalized, science-backed treatment plans to achieve the best possible care. Independent and trusted by leading employers and providers alike, PHM helps individuals make confident decisions that lead to better outcomes. Learn more at www.privatehealth.com.
Citations:
- American Cancer Society, “Cancer Facts & Figures 2025,” 2025. Cancer Facts & Figures 2025
- NIHCM Foundation, “Insights on Cancer: Rates, Costs, and Strategies” December 2024. Insights on Cancer: Rates, Costs, and Strategies
- Private Health Management. (2025, January). Improving cancer survival: PHM’s impact on cancer care
View source version on businesswire.com: https://www.businesswire.com/news/home/20250904488273/en/
Media Contact:
Liz Harish
929-343-7473
elizabeth.harish@metlife.com
Source: MetLife, Inc.